Item 5. Other Information

The following table describes contracts, instructions or written plans for the sale or purchase of our securities adopted or terminated by our directors or officers during the third quarter of fiscal 2025 that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act (Rule 10b5-1 trading arrangement).


Name and Title	Action	Date of Adoption/ Termination	Duration of Rule 10b5-1 Trading Arrangement	Aggregate Number of Securities to Be Purchased or Sold
Vincent Roche Chief Executive Officer and Chair of the Board of Directors	Termination	May 23, 2025 (1)	Until May 1, 2026, or such earlier date upon which all transactions are completed or expire without execution	Sale of up to 140,000 shares (2)
Vincent Roche Chief Executive Officer and Chair of the Board of Directors	Adoption	May 23, 2025 (1)	Until May 1, 2026, or such earlier date upon which all transactions are completed or expire without execution	Sale of up to 90,000 shares

(1)Represents the modification, as described in Rule 10b5-1(c)(1)(iv) under the Exchange Act, of a Rule 10b5-1 trading arrangement originally adopted on March 13, 2025.

(2)As of the date of termination, no shares of our common stock had been sold under the Rule 10b5-1 trading arrangement.

None of our officers or directors adopted or terminated a non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K) during the third quarter of fiscal 2025.

Previous: Item 1A. Risk Factors · Next: Item 6. Exhibits